Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver.

Saved in:
Bibliographic Details
Title: Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver.
Authors: Kurtz CL; Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Fannin EE; Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Toth CL; Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN, USA., Pearson DS; Children's Hospital Boston, Harvard Medical School, Boston, MA, USA., Vickers KC; Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN, USA., Sethupathy P; 1] Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA [2] Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, NC, USA.
Source: Scientific reports [Sci Rep] 2015 Aug 06; Vol. 5, pp. 12911. Date of Electronic Publication: 2015 Aug 06.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26246194
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kurtz+CL%22">Kurtz CL</searchLink>; Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Fannin+EE%22">Fannin EE</searchLink>; Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Toth+CL%22">Toth CL</searchLink>; Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Pearson+DS%22">Pearson DS</searchLink>; Children's Hospital Boston, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Vickers+KC%22">Vickers KC</searchLink>; Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Sethupathy+P%22">Sethupathy P</searchLink>; 1] Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA [2] Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, NC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2015 Aug 06; Vol. 5, pp. 12911. <i>Date of Electronic Publication: </i>2015 Aug 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26246194
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/srep12911
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 12911
    Titles:
      – TitleFull: Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kurtz CL
      – PersonEntity:
          Name:
            NameFull: Fannin EE
      – PersonEntity:
          Name:
            NameFull: Toth CL
      – PersonEntity:
          Name:
            NameFull: Pearson DS
      – PersonEntity:
          Name:
            NameFull: Vickers KC
      – PersonEntity:
          Name:
            NameFull: Sethupathy P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 08
              Text: 2015 Aug 06
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 2045-2322
          Numbering:
            – Type: volume
              Value: 5
          Titles:
            – TitleFull: Scientific reports
              Type: main
ResultId 1